Medeloop

Medeloop

AI-driven platform for clinical research management

Overview

Medeloop is an AI-driven platform that speeds up clinical and public health research. It serves researchers, pharmaceutical companies, and healthcare providers by covering the full research lifecycle—from generating hypotheses and helping with funding to managing studies and analyzing data. The platform is accessed through subscriptions and includes tools like two-way messaging for patient-care team communication, advanced analytics to identify biomarkers and drug targets, and features for grant writing and scientific publication. Medeloop integrates and harmonizes large health data sources to streamline research workflows. This helps shorten discovery timelines and aim for better patient outcomes. The company operates in health-tech with a focus on early-stage clinical research and trials, positioning itself as a comprehensive, data-driven research platform rather than a collection of isolated tools.

Significant Headcount Growth

About Medeloop

Simplify's Rating
Why Medeloop is rated
C
Rated C on Competitive Edge
Rated B on Growth Potential
Rated D+ on Differentiation

Industries

Data & Analytics

Enterprise Software

AI & Machine Learning

Healthcare

Company Size

11-50

Company Stage

Series A

Total Funding

$23.5M

Headquarters

Palo Alto, California

Founded

2021

Get referred to Medeloop

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • HealthVerity partnership exposes Medeloop to 200 million de-identified records and enterprise buyers.
  • Series A closed November 13, 2024 raised $15.5 million, extending runway and hiring capacity.
  • The Stanford CRPS trial validates Medeloop’s data capture, likely strengthening sales proof through 2026.

What critics are saying

  • HealthVerity controls distribution, so Medeloop risks becoming a replaceable analytics layer by 2027.
  • ChatGPT App Store dependency lets OpenAI disintermediate Medeloop and own the clinical-research interface.
  • Clinical research software is crowded; Epic, Veeva, and Databricks can bundle similar AI features, crushing pricing.

What makes Medeloop unique

  • Medeloop embeds agentic research workflows directly into HealthVerity eXOs, launched September 30, 2025.
  • Medeloop Grants launched on ChatGPT App Store April 27, 2026, reducing workflow friction.
  • Stanford’s CRPS study updated May 8, 2026 uses Medeloop for real-time wearable analysis.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$23.5M

Above

Industry Average

Funded Over

2 Rounds

Notable Investors:
Series A funding typically happens when a startup has a product and some customers, and now needs funding to scale. This money is usually used to grow the team, expand marketing, and improve the product. Venture capital firms are frequently the main investors here.
Series A Funding Comparison
Meet Average

Industry standards

$15M
$8.2M
Discord
$15M
Canva
$15.5M
Medeloop
$30M
Kalshi

Benefits

Flexible Work Hours

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

7%

1 year growth

7%

2 year growth

5%
HealthVerity
Jun 4th, 2025
HealthVerity and Medeloop Announce Strategic Partnership to Enhance Real-World Evidence Insights with AI-Driven Analytics

This powerful collaboration unites HealthVerity's extensive, privacy-compliant data ecosystem with Medeloop's cutting-edge AI Agent Analytics technology, enabling customers to uncover insights with unprecedented speed and transform vast, complex datasets into clear, actionable intelligence.

Startup Rise USA
Nov 18th, 2024
[Funding news] CA-based Medeloop has Secured $15.5 Million in Series A Round Funding

Medeloop, a medical research platform, has raised $15.5 million in Series A funding led by Inovia Capital, with support from Icon Ventures, General Catalyst, Maven Ventures, and new investors like Healthier Capital, Up2 Opportunity Fund, and CFO Advisors.

HIT Consultant
Nov 13th, 2024
Medeloop Secures $15.5M for AI Research

Medeloop has raised $15.5M in Series A funding, led by Inovia Capital with participation from Icon Ventures, General Catalyst, and Maven Ventures. The funds will enhance Medeloop's AI-driven medical research platform, which accelerates research by using autonomous AI agents and a graph database for faster data analysis. The platform includes tools for grant applications, clinical study management, data analysis, and manuscript publication.

Financial Post
Nov 13th, 2024
Medeloop Secures $15.5 Million in Series A Funding to Accelerate Medical Research

MENLO PARK, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) - Medeloop, the pioneering medical research platform announces the close of its $15.5 million Series A funding round.

Yahoo Finance
May 6th, 2024
Healthier Capital Founder and Former One Medical CEO Endorses Medeloop Amid Launch of New AI Research Agent

MENLO PARK, Calif., May 06, 2024 (GLOBE NEWSWIRE) - Medeloop, a trailblazer AI platform for clinical research is proud to announce the addition of Amir Dan Rubin to its board of directors.

Recently Posted Jobs

Sign up to get curated job recommendations

Medeloop is Hiring for 3 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →